期刊文献+

30例肾肿瘤患者的临床治疗体会 被引量:1

Renal Tumor: Clinical Experience with 30 Cases
下载PDF
导出
摘要 目的探讨肾肿瘤患者手术治疗的临床意义。方法对30例肾肿瘤患者的临床资料进行回顾性分析。所有患者术前均经B超、CT或MRI及静脉肾盂造影检查,根据患者病情采取肾癌根治术、单纯肾切除及部分肾切除术,术后辅以生物免疫治疗。结果 30例患者术后病理证实为透明细胞癌25例,乳头状细胞癌1例,囊腺癌1例,未获得病理结果(术中探查高度怀疑为恶性肿瘤)1例,良性肾腺瘤2例。30例患者均获2~36个月的随访,其中3例Ⅳ期肾癌、1例Ⅲ期肾癌伴有双肾结石及左肾囊肿患者术后24个月死亡。26例患者均无瘤生存,无一例局部复发或转移。结论肾肿瘤的临床表现多样化,早期发现和治疗是提高肾肿瘤患者生存率的关键。 Objective To explore the clinical significance of the treatment of renal tumor. Methods Clinical data of 30 cases of kidney cancer were retrospectively analyzed. All patients underwent B ultrasound, CT or MRI and intravenous pyelogram before operation. According to the state of illness, patients were treated with radical nephrectomy, simple nephrectomy or partial nephrectomy in combination with postoperative immunotherapy. Results Among the 30 patients, clear cell carcinoma was pathologically confirmed in 25, papillary renal cell carcinoma in 1, cystadenocarcinoma in 1, and benign renal adenoma in 2. No pathological findings were obtained in 1 patient with suspected malignancy. All patients were followed up for 2-36 months. Three of the 30 patients had stage IV renal cell carcinoma, 1 had stage III renal cell carcinoma with dual kidney stones and left kidney cyst and died 24 months after operation. Twenty-six patients survived without tumors and no one had local recurrence or metastasis. Conclusion Renal tumors have diversified clinical manifestations. Early detection and treatment are the key to improving survival rates in patients with kidney tumors.
作者 王月生
出处 《实用临床医学(江西)》 CAS 2013年第4期43-45,共3页 Practical Clinical Medicine
关键词 肾肿瘤 外科手术 治疗 renal tumor surgery treatment
  • 相关文献

参考文献10

  • 1高艳,曹水,任秀宝.舒尼替尼对转移性肾癌患者髓系来源抑制细胞的影响[J].国际免疫学杂志,2011,34(1):53-56. 被引量:3
  • 2张世林,叶定伟,姚旭东,戴波,张海梁,朱耀,沈益君.膀胱偶发肿瘤的的诊断与治疗[J].中国癌症杂志,2007,17(3):255-257. 被引量:11
  • 3Gkialas I K,Papadopoulos G. New therapeutic approaches in the management of metastatic renal cell carcinoma[J]. J BUON,2009,14 (3):399-404.
  • 4Fisher R,Gore M,Larkin J,et al.Current and future systemic treatments for renal cell carcinoma [J].Semin Cancer Biol,2012,13 (6):231-240.
  • 5李鸣,何志嵩,高江平,孙颖浩,李长岭,黄翼然,孙光,王国民.多中心肾癌临床特征分析[J].中华泌尿外科杂志,2010,31(2):77-80. 被引量:74
  • 6李虹,张宏印,张玉梅.24例肾癌患者术后长期随访观察[J].中国老年学杂志,2011,31(3):522-523. 被引量:3
  • 7Janzen N K,Kim H L,Figlin R A,et al.Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease [J].Urol Clin North Am,2003,30(4):843-852.
  • 8Russo P, Synder M,Vickers A,et al.Cytoreductive nephr- ectomy and nephrectomy/complete metastasectomy for metastatic renal cancer [J].Scientific World Journal,2007, 7:768-778.
  • 9Russo P.Surgical intervention in patients with metastatic renal cancer: current status of metastasectomy and cyto- reductive nephrectomy[J]. Nat Clin Pract Urol,2004,1 ( 1 ):26-30.
  • 10孙士恒.手术治疗肾肿瘤患者的临床分析[J].中外健康文摘,2012,9(24):84.

二级参考文献54

  • 1Obara W, Mizutani Y, Oyama C, et al. Prospective study of combined treatment with interferon alpha and active vitamin D3 for Japanese patients with metastatic renal cell carcinoma. Int J Urol, 2008, 15: 794-799.
  • 2Gupta K, Miller JD, Li JZ, et al. Epidemiologic and socioe conomic burden of metastatic renal cell carcinoma (mRCC) : a literature review. Cancer Treat Rev, 2008, 34:193-205.
  • 3Taari K, Perttila I, Nisen H. Laparoscopic versus open nephrectomy for renal cell carcinoma? Scand J Surg, 2004, 93:132-136.
  • 4Rubinstein M, Moinzadeh A, Colombo JR Jr. Energy sources for laparoscopic partial nephrectomy critical appraisal. Int Braz J Urol, 2007, 33:3-10.
  • 5Chapman TN, Sharma S, Zhang S. Laparoscopic lymph node dissection in clinically node-negative patients undergoing laparoscopic nephrectomy for renal carcinoma. Urology, 2008, 71:287-291.
  • 6Godoy G, O'Malley RL, Taneja SS. Lymph node dissection during the surgical treatment of renal cancer in the modern era. Int Braz J Urol, 2008, 34: 132-142.
  • 7Margulis V, Wood CG. The role of lymph node dissection in renal cell carcinoma: the pendulum swings back. Cancer J, 2008, 14: 308-314.
  • 8Leibovich BC, Blute ML. Lymph node dissection in the management of renal cell carcinoma. Urol Clin North Am, 2008, 35: 673-678.
  • 9Blom JH, van Poppel H, Marechal JM, et al. Radical nephrectomy with and without lymph node dissection: Final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol, 2009, 55:28-34.
  • 10Sinha P, Clements VK, Ostrand-Rosenberg S. Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J Immunol, 2005,174(2) :636-645.

共引文献87

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部